PRAH  valuation analysis

Basics
Name: PRA Health Sciences, Inc
Description: PRA Health Sciences, Inc., a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. (more)
Industry: Diagnostics & Research
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: Nov 04, 2020
Market cap: $9.39B (453rd)
Sales(TTM): $3.11B (542nd)
Earnings(TTM): $220.59M (495th)

Value
FFER: 1.91*
Actual price: $146.44
* Earnings were reported Feb 18, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-03-05
Price & Estimates
Sales & Earnings history (TTM)
Notable
No notables found through heuristics.
Earnings / MarketCap
PRA Health Sciences, Inc
"Diagnostics & Research" industry
Sales / MarketCap
PRA Health Sciences, Inc
"Diagnostics & Research" industry
Book / MarketCap
PRA Health Sciences, Inc
"Diagnostics & Research" industry
Equity / Assets
PRA Health Sciences, Inc
"Diagnostics & Research" industry